Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Dec 15, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vericel Corp
| -5.00K |
$37.31 | -$186,550.00 | -15.72% | 26.8K |
Dec 14
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
May 3
| |||||||
Vericel Corp
| 2.6K |
—
|
—
| +8.90% | 31.8K |
Apr 27
| |||||||
Vericel Corp
| 2.6K |
—
|
—
| +9.77% | 29.2K |
Apr 27
| |||||||
Vericel Corp
| -5.00K |
$50.52 | -$252,611.00 | -15.82% | 26.6K |
May 14
| |||||||
Vericel Corp
| 28.1K |
$32.25 | -$143,843.39 | +802.91% | 31.6K |
May 11 - May 12
| |||||||
Vericel Corp
| 1.75K |
—
|
—
| +100.00% | 3.5K |
Apr 28
| |||||||
Vericel Corp
| 1.75K |
—
|
—
|
∞
| 1.75K |
Apr 29
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
May 1
| |||||||
Vericel Corp
|
0
|
$9.74 | -$318,868.00 |
—
|
0
|
Jan 2
|
Scheduled
| ||||||
Vericel Corp
|
0
|
$7.74 | -$259,400.00 |
—
|
0
|
Jun 18
|
Scheduled
| ||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
May 2
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
May 3
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
May 4
| |||||||
Ocata Therapeutics, Inc.
| -277.50K |
$8.50 | -$2,358,750.00 | -100.00% |
0
|
Feb 10
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ocata Therapeutics, Inc.
| -32.50K |
$4.23 | -$137,475.00 | -10.83% | 267.5K |
Jul 30
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 20
| |||||||
Ocata Therapeutics, Inc.
| 10K |
—
|
—
| +3.33% | 310K |
Mar 5
| |||||||
Vericel Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Advanced Cell Technology, Inc.
| 30M |
—
|
—
|
∞
| 30M |
Jul 30
| |||||||
Advanced Cell Technology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Antares Pharma, Inc.
| 266.99K |
—
|
—
| +39.81% | 937.73K |
May 29
| |||||||
Antares Pharma, Inc.
| 7K |
$4.85 | -$16,048.65 | +1.05% | 670.73K |
Feb 20
| |||||||
Antares Pharma, Inc.
| -45.00K |
$4.45 | -$48,950.00 | -6.35% | 663.73K |
Feb 11
| |||||||
Antares Pharma, Inc.
|
0
|
$2.80 | -$105,307.94 |
—
| 708.73K |
Jan 15
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.25 | -$224,594.86 |
—
| 708.73K |
Dec 6 - Dec 9
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.35 | -$129,010.00 |
—
| 708.73K |
Oct 1
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.46 | -$136,878.00 |
—
| 708.73K |
Sep 3
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.46 | -$137,091.50 |
—
| 708.73K |
Aug 1
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.32 | -$127,473.50 |
—
| 708.73K |
Jul 1
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.26 | -$438,637.50 |
—
| 708.73K |
Jun 3
|
Scheduled
| ||||||
Antares Pharma, Inc.
| 185.19K |
—
|
—
| +35.37% | 708.73K |
May 22
| |||||||
Antares Pharma, Inc.
|
0
|
$2.27 | -$35,350.00 |
—
| 523.55K |
May 6
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.26 | -$87,800.00 |
—
| 537.39K |
Jan 8
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.25 | -$87,507.50 |
—
| 537.39K |
Dec 4
|
Scheduled
| ||||||
Antares Pharma, Inc.
| 54.77K |
—
|
—
| +11.35% | 537.39K |
Jul 6
| |||||||
Antares Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 17
| |||||||
Antares Pharma, Inc.
| 6.95K |
—
|
—
| +1.46% | 482.62K |
Feb 10
| |||||||
Antares Pharma, Inc.
| 45.16K |
—
|
—
| +10.49% | 475.67K |
Sep 9
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.